Results 181 to 190 of about 1,980,096 (243)

Infections and their determinants in patients with non‐Hodgkin lymphoma receiving bispecific T‐cell antibodies: Results from an international multicenter cohort study

HemaSphere, Volume 10, Issue 11, November 2026.
Zainab Shahid, Michelle Okwali, Ashlee Joseph, David Nemirovsky, Derkach Andriy, Clare Grieve, Rafaella Tringale, Reid Merryman, Aaron Zou, Silvia Ferrari, Monica Rondi, Sean Harrop, Divya Somasekharannair, Jennifer Crombie, Gilles Salles, Giuseppe Gritti, Michael Dickinson, Lorenzo Falchi   +17 more
wiley   +1 more source

Inflammatory Pseudotumour in Common Seal (Phoca vitulina): A Case Report

Veterinary Medicine and Science, Volume 12, Issue 6, November 2026.
A 19‐year‐old intact male common seal (Phoca vitulina) diagnosed with a chronic ulcer. Microbiology identified Vibrio alginolyticus. Radiography noted phalanx alterations. Macroscopic, histopathological, and immunohistochemical examinations revealed a neoplastic origin with a myofibroblastic phenotype. This report describes the first documented case of
Javier M. De Pablo‐Moreno, Rocío Canales, Mireia Mainez, Nicolás Aradilla, Blanca Chinchilla, Néstor Porras, Ignacio Vargas‐Castro, Antonio Rodríguez‐Bertos   +7 more
wiley   +1 more source

Trained Immunity in Childhood Vaccination

Acta Paediatrica, Volume 115, Issue 11, Page 2402-2413, November 2026.
Trained immunity as an emerging concept in paediatric vaccinology. Trained immunity links vaccine stimuli through epigenetic and metabolic reprogramming to enhanced innate immune cell function, thereby strengthening protection against diverse pathogens while promoting adaptive immune responses through more efficient antigen presentation and co ...
ChenRongRong Cai, Lubnaa Hossenbaccus, Eva Kaufmann   +2 more
wiley   +1 more source

Real‐World Safety and Efficacy of Pola‐R‐CHP in Previously Untreated DLBCL: POLASTAR Interim Analysis of 500 Patients

Cancer Science, Volume 117, Issue 11, Page 3098-3107, November 2026.
In this analysis of a diverse cohort of 500 patients with previously untreated DLBCL in a real‐world clinical setting, Pola‐R‐CHP demonstrated high response rates at end‐of‐treatment, which were consistent among the overall population, in patients > 80 years and regardless of International Prognostic Index status and cell of origin subtypes.
Takahiro Kumode, Hitomi Sawa, Kohta Miyawaki, Atsushi Satake, Nobuhiro Kanemura, Ritsuro Suzuki, Yuki Fujiwara, Yasuhiro Nagate, Shuichi Ota, Takahiro Fujino, Hideki Goto, Noriko Fukuhara, Mamiko Sakata‐Yanagimoto, Koji Izutsu, Momoko Nishikori, Hirohiko Shibayama, Daisuke Ennishi, Takayuki Shimose, Mai Asai, Itaru Matsumura, Koichi Akashi, Koji Kato   +21 more
wiley   +1 more source

Immune Consequences of Metabolic Syndrome and Its Treatment: A Cytokine Perspective

Immunology, Volume 179, Issue 3, Page 390-405, November 2026.
Peripheral blood mononuclear cells (PBMCs) from individuals with metabolic syndrome (MetS) who were not using glucose‐and/or lipid lowering medication (GLLM) exhibited a broader cytokine production profile after in vitro antigen‐specific stimulation than PBMCs from individuals with MetS using such medications and from healthy donors.
Isabela Ghetti Macedo Isaac, Carolina do Prado Servian, Fernanda de Oliveira Feitosa de Castro, João Lucas Lima Calandrini de Azevedo, Ronaldo Moraes Preto, Miriam Leandro Dorta, Daniela Espíndola Antunes, Simone Gonçalves Fonseca   +7 more
wiley   +1 more source

Clinical Impact of Haemophagocytic Lymphohistiocytosis Among Patients With HIV/AIDS and Disseminated Histoplasmosis in a Hyperendemic Region of Northeastern Brazil

Mycoses, Volume 69, Issue 11, November 2026.
ABSTRACT Background Haemophagocytic lymphohistiocytosis (HLH) is a life‐threatening hyperinflammatory syndrome that may occur in people living with HIV/AIDS (PLWHA), often triggered by opportunistic infections such as disseminated histoplasmosis (DH).
Matheus Alves de Lima Mota, Marcos Maciel Sousa, João Victor Monteiro Souza, Italo Oliveira Moura, Jéssica Maria de Sousa Oliveira, Jacó Ricarte Lima de Mesquita, Lisandra Serra Damasceno, Terezinha do Menino Jesus Silva Leitão, Gdayllon Cavalcante Meneses, Elizabeth De Francesco Daher   +9 more
wiley   +1 more source

Investigation of Torque Teno Virus Loads as a Marker of Immunosuppression in Pediatric Chronic Renal Failure: A Pilot Study

Pediatric Transplantation, Volume 30, Issue 11, November 2026.
TTV is a promising marker to assess immune competence in a cohort of pediatric renal transplant recipients. Based on our data, immunosuppressive status and gender‐related factors affect TTV kinetics after transplantation and should be considered when interpreting TTV as a biomarker of immune function. ABSTRACT Background Torque Teno Virus (TTV), family
Ellen Kelly, Atif Awan, Dermot Wildes, Cillian F. De Gascun, Richard J. Drew, Alessandra Heggenstaller, Michael Riordan, Jaythoon Hassan   +7 more
wiley   +1 more source

Baricitinib as Salvage Therapy for Multidrug‐Resistant Chronic Graft‐Versus‐Host Disease

MedComm, Volume 7, Issue 11, November 2026.
Zhuo‐Yu An, Chen Zhao, Yuanyuan Zhang, Xiaodong Mo, Leqing Cao, Daoxing Deng, Jun Kong, Fengrong Wang, Xiaojun Huang, Xiaohui Zhang   +9 more
wiley   +1 more source

Maximising Cancer Prevention and Early Detection in the Australian Cancer Plan: Where Are We Now and What Should Come Next?

Medical Journal of Australia, Volume 224, Issue 11, November 2026.
ABSTRACT Cancer accounts for three in 10 deaths in Australia, yet many cases are preventable or can be detected at an early stage. Maximising cancer prevention and early detection is one of the six strategic objectives of the 10‐year Australian Cancer Plan.
Erin L. Symonds, Billie Bonevski, Richard Edwards, Nathan J. Harrison, Sana Ishaque, Nicole M. Rankin, Sibel Saya, Renee J. Smith, Carolyn Ee   +8 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Epstein–Barr Virus Infection

New England Journal of Medicine, 2000
The Epstein–Barr virus (EBV) was discovered 36 years ago by electron microscopy of cells cultured from Burkitt's lymphoma tissue by Epstein, Achong, and Barr.1 Four years later, in 1968, EBV was shown to be the etiologic agent of heterophile-positive infectious mononucleosis.2 EBV DNA was detected in tissues from patients with nasopharyngeal carcinoma ...
Jeffrey I Cohen
openaire   +4 more sources